CNR1 抗体
(Cannabinoid Receptor 1 (CNR1))
This gene encodes one of two cannabinoid receptors. The cannabinoids, principally delta-9-tetrahydrocannabinol and synthetic analogs, are psychoactive ingredients of marijuana. The cannabinoid receptors are members of the guanine-nucleotide-binding protein (G-protein) coupled receptor family, which inhibit adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner. The two receptors have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. Multiple transcript variants encoding two different protein isoforms have been described for this gene. [provided by RefSeq, May 2009].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| CNR1 抗体 (Center) | 人 | 兔 Polyclonal |
|
|
|
| CNR1 抗体 | 人 | Human Monoclonal |
|
|
|
| CNR1 抗体 (APC) | 人 | Human Monoclonal |
|
|
|
| CNR1 抗体 (FITC) | 人 | Human Monoclonal |
|
|
|
| CNR1 抗体 (PE) | 人 | Human Monoclonal |
|
|
|
| CNR1 抗体 (PerCP) | 人 | Human Monoclonal |
|
|
|
| Recombinant CNR1 抗体 | 人 | Alpaca Monoclonal |
|
|
|
| Recombinant CNR1 抗体 | 人 | Human Monoclonal |
|
|
|
| CNR1 抗体 | 人 | 兔 Polyclonal |
|
|
|
| CNR1 抗体 (AA 1-77) | 大鼠 | 兔 Polyclonal |
|
|
|
| CNR1 抗体 (AA 1-99) | 人 | 兔 Polyclonal |
|
|
|
| CNR1 抗体 (Alexa Fluor 680) | 人 | 兔 Polyclonal |
|
|
|
| CNR1 抗体 (Alexa Fluor 555) | 人 | 兔 Polyclonal |
|
|
|
| CNR1 抗体 (Alexa Fluor 750) | 人 | 兔 Polyclonal |
|
|
|
| CNR1 抗体 (Alexa Fluor 647) | 人 | 兔 Polyclonal |
|
|
|
| CNR1 抗体 (Alexa Fluor 594) | 人 | 兔 Polyclonal |
|
|
|
| CNR1 抗体 (Alexa Fluor 488) | 人 | 兔 Polyclonal |
|
|
|
| CNR1 抗体 (C-Term) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| CNR1 抗体 (PE) | 人 | 兔 Monoclonal |
|
|
|
| CNR1 抗体 (C-Term) (SureLight® R-PE) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 161-187, Center
Primary Antibody
- 适用
- 人
- 宿主
- Human
- 克隆形成能力
- Monoclonal
- 克隆
- ABS1289
- 标记
- PerCP
- 抗体亚型
- IgG4, kappa
Primary Antibody
- 适用
- 人
- 宿主
- Alpaca
- 克隆形成能力
- Monoclonal
- 克隆
- SAA1274
- 标记
- unconjugated
- Fragment
- single-domain Antibody (sdAb)
- 蛋白类型
- Recombinant Antibody
Primary Antibody
- 适用
- 人
- 宿主
- Human
- 克隆形成能力
- Monoclonal
- 克隆
- GFB-024
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IC (Immunochromatography: 所列应用)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-77
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IC (Immunochromatography: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-99
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- DM144
- 标记
- PE
- 抗体亚型
- IgG
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- MA (Microarray: 所列应用)
- CA (Cellular Assay: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- SureLight® R-PE
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Latest Publications for our CNR1 抗体
: "Barrier-Strengthening Effects of Cannabidiol on Porcine Peyer's Patches." in: International journal of molecular sciences, Vol. 26, Issue 7, (2025) (PubMed).
: "Cannabidiol attenuates inflammatory impairment of intestinal cells expanding biomaterial-based therapeutic approaches." in: Materials today. Bio, Vol. 23, pp. 100808, (2023) (PubMed).
: "Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain." in: Neuropharmacology, Vol. 129, pp. 1-15, (2018) (PubMed).
: "Increased placental expression of cannabinoid receptor 1 in preeclampsia: an observational study." in: BMC pregnancy and childbirth, Vol. 14, pp. 395, (2015) (PubMed).
: "Developmental molecular and functional cerebellar alterations induced by PCP4/PEP19 overexpression: implications for Down syndrome." in: Neurobiology of disease, Vol. 63, pp. 92-106, (2014) (PubMed).
: "Dysfunction in fatty acid amide hydrolase is associated with depressive-like behavior in Wistar Kyoto rats." in: PLoS ONE, Vol. 7, Issue 5, pp. e36743, (2012) (PubMed).
: "Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivo." in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine, Vol. 51, Issue 9, pp. 1413-7, (2010) (PubMed).
: "Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain." in: Journal of clinical psychopharmacology, Vol. 30, Issue 4, pp. 441-5, (2010) (PubMed).
: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).
: "Expression of cannabinoid receptors in human kidney." in: Histology and histopathology, Vol. 25, Issue 9, pp. 1133-8, (2010) (PubMed).
: "Cannabidiol attenuates inflammatory impairment of intestinal cells expanding biomaterial-based therapeutic approaches." in: Materials today. Bio, Vol. 23, pp. 100808, (2023) (PubMed).
: "Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain." in: Neuropharmacology, Vol. 129, pp. 1-15, (2018) (PubMed).
: "Increased placental expression of cannabinoid receptor 1 in preeclampsia: an observational study." in: BMC pregnancy and childbirth, Vol. 14, pp. 395, (2015) (PubMed).
: "Developmental molecular and functional cerebellar alterations induced by PCP4/PEP19 overexpression: implications for Down syndrome." in: Neurobiology of disease, Vol. 63, pp. 92-106, (2014) (PubMed).
: "Dysfunction in fatty acid amide hydrolase is associated with depressive-like behavior in Wistar Kyoto rats." in: PLoS ONE, Vol. 7, Issue 5, pp. e36743, (2012) (PubMed).
: "Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivo." in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine, Vol. 51, Issue 9, pp. 1413-7, (2010) (PubMed).
: "Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain." in: Journal of clinical psychopharmacology, Vol. 30, Issue 4, pp. 441-5, (2010) (PubMed).
: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).
: "Expression of cannabinoid receptors in human kidney." in: Histology and histopathology, Vol. 25, Issue 9, pp. 1133-8, (2010) (PubMed).
Aliases for CNR1 抗体
cannabinoid receptor 1 (CNR1) 抗体cannabinoid receptor 1 (brain) (Cnr1) 抗体
cannabinoid receptor 1 (Cnr1) 抗体
cannabinoid receptor 1 (cnr1) 抗体
cannabinoid receptor 1 (brain) S homeolog (cnr1.S) 抗体
CANN6 抗体
CB-R 抗体
CB1 抗体
CB1A 抗体
CB1K5 抗体
CB1R 抗体
CNR 抗体
cnr1-A 抗体
SKR6R 抗体
您还需要查找其他产品吗？
- CNPY4 抗体
- CNPY2/MSAP 抗体
- Cnpase 抗体
- CNOT8 抗体
- CNOT6 抗体
- CNOT3 抗体
- CNOT2 抗体
- CNOT11 抗体
- CNOT1 抗体
- CNNM4 抗体
- CNN3 抗体
- CNN2 抗体
- CNN1 抗体
- CNKSR3 抗体
- CNKSR2 抗体
- CNKSR1 抗体
- CNIH3 抗体
- CNIH2 抗体
- CNIH 抗体
- CNGB3 抗体
- CNR2 抗体
- Cnrip1 抗体
- CNST 抗体
- CNTF 抗体
- CNTF Receptor alpha 抗体
- CNTN2 抗体
- CNTN3 抗体
- CNTNAP1 抗体
- CNTNAP2 抗体
- CNTNAP3 抗体
- CNTNAP4 抗体
- CNTNAP5 抗体
- CNTROB 抗体
- Coagulation Factor II (thrombin) Receptor-Like 2 抗体
- Coagulation Factor IX 抗体
- Coagulation Factor V 抗体
- Coagulation Factor VIII-Associated 1 抗体
- Coagulation Factor X 抗体
- COASY 抗体
- COBRA1 抗体
You are here:
